|
ARHGEF12 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.629780E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.633400E-01 |
| Normal-vs-Stage2 |
5.027600E-01 |
| Normal-vs-Stage3 |
3.557900E-02 |
| Normal-vs-Stage4 |
2.778500E-02 |
| Stage1-vs-Stage2 |
9.336600E-01 |
| Stage1-vs-Stage3 |
1.027790E-01 |
| Stage1-vs-Stage4 |
1.256640E-01 |
| Stage2-vs-Stage3 |
2.232200E-01 |
| Stage2-vs-Stage4 |
1.775780E-01 |
| Stage3-vs-Stage4 |
7.758800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.663390E-01 |
| Normal-vs-AfricanAmerican |
8.718800E-01 |
| Normal-vs-Asian |
9.164500E-02 |
| Caucasian-vs-AfricanAmerican |
4.295400E-01 |
| Caucasian-vs-Asian |
5.815600E-01 |
| AfricanAmerican-vs-Asian |
2.654000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.380400E-02 |
| Normal-vs-Female |
2.914200E-01 |
| Male-vs-Female |
1.329010E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.839600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.310430E-01 |
| Normal-vs-Age(61-80Yrs) |
6.368000E-02 |
| Normal-vs-Age(81-100Yrs) |
3.299700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.154600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.558560E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.181380E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.094000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.658040E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.758200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.786100E-02 |
| Classical-VS-Follicular |
4.288200E-02 |
| Classical-VS-Other |
1.148560E-01 |
| Classical-VS-Normal |
5.742600E-01 |
| Tall-VS-Follicular |
8.691400E-01 |
| Tall-VS-Other |
3.137400E-01 |
| Tall-VS-Normal |
6.158000E-02 |
| Follicular-VS-Other |
3.582400E-01 |
| Follicular-VS-Normal |
4.942000E-02 |
| Other-VS-Normal |
5.632400E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.945900E-02 |
| Normal-vs-N1 |
7.060300E-02 |
| N0-vs-N1 |
6.527000E-01 |
|
|
